A detailed history of Jump Financial, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Jump Financial, LLC holds 50,832 shares of CRSP stock, worth $2.27 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
50,832
Holding current value
$2.27 Million
% of portfolio
0.05%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$44.62 - $62.75 $2.27 Million - $3.19 Million
50,832 New
50,832 $2.39 Million
Q4 2023

Oct 21, 2024

BUY
$38.62 - $72.18 $351,828 - $657,559
9,110 Added 27.35%
42,417 $2.66 Million
Q4 2023

Feb 07, 2024

BUY
$38.62 - $72.18 $351,828 - $657,559
9,110 Added 27.35%
42,417 $2.66 Million
Q3 2023

Oct 21, 2024

BUY
$45.39 - $59.0 $998,852 - $1.3 Million
22,006 Added 194.73%
33,307 $1.51 Million
Q3 2023

Nov 07, 2023

BUY
$45.39 - $59.0 $998,852 - $1.3 Million
22,006 Added 194.73%
33,307 $1.51 Million
Q2 2023

Oct 21, 2024

SELL
$43.47 - $67.77 $4.84 Million - $7.54 Million
-111,258 Reduced 90.78%
11,301 $634,000
Q2 2023

Aug 07, 2023

SELL
$43.47 - $67.77 $4.84 Million - $7.54 Million
-111,258 Reduced 90.78%
11,301 $634,000
Q1 2023

Oct 21, 2024

BUY
$41.0 - $56.12 $5.02 Million - $6.88 Million
122,559 New
122,559 $5.54 Million
Q1 2023

May 03, 2023

BUY
$41.0 - $56.12 $2.76 Million - $3.78 Million
67,372 Added 122.08%
122,559 $5.54 Million
Q4 2022

Feb 13, 2023

BUY
$39.19 - $65.67 $2.16 Million - $3.62 Million
55,187 New
55,187 $2.24 Million
Q2 2022

Aug 09, 2022

SELL
$43.23 - $73.83 $274,207 - $468,303
-6,343 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$53.19 - $79.24 $337,384 - $502,619
6,343 New
6,343 $398,000
Q4 2021

Feb 10, 2022

SELL
$70.09 - $111.29 $200,807 - $318,845
-2,865 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$110.2 - $156.64 $315,723 - $448,773
2,865 New
2,865 $320,000
Q2 2021

Aug 13, 2021

SELL
$100.84 - $161.89 $534,452 - $858,016
-5,300 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$110.72 - $210.04 $586,816 - $1.11 Million
5,300 New
5,300 $646,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.48B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.